Admissions:
None
Delistings:
None
Potential** Initial Public Offerings:
Updated 10th June: iFOREX Financial Trading, the fintech business with a proprietary online and mobile trading platform for multi-asset contracts for difference, announced that its proposed IPO onto the Main Market, which was expected to occur in late June, will be briefly delayed. A routine thematic compliance inspection commenced earlier this year in the BVI, which was disclosed in the Company's Registration Document, requires additional time to enable finalisation ahead of the IPO. The inspection process is close to completion and the Company anticipates only a short delay to the IPO timetable. The Company reports the IPO has received strong investor interest and based on firm orders received to date, the institutional offer is heavily oversubscribed. Deal size and timing remains TBC.
Market Movers:
Updated 4 June 2025: Ajax Resources (AJAX.L) is planning to move to the Aquis Stock Exchange Growth Market Access Category from the Main Market of the London Stock Exchange. The Company expects cancellation to take place at 08:00 BST on 18 June 2025, with Admission to trading on AQSE to occur concurrently. Ajax is pursuing a strategy as a natural resources investment company, with a focus on Copper, Gold, Zinc, Uranium, and Lead. The Company completed its first acquisition on 21 May 2025. The Company’s first acquisition was the purchase of Puna Metals S.A., holding the mining rights for 12 licences, collectively forming the Eureka Gold and Copper project in the north-west corner of the Province of Jujuy in Argentina.
Abingdon Health 7.0p £12.6m (ABDX.L)
The leading international developer, manufacturer, and distributor of high quality and effective rapid tests announces a new EUR2m contract win with a leading European biotech company for the continued development and regulatory approval of a companion diagnostic lateral flow point of care test. Most of this project and associated revenue will fall into FY26. Following the successful completion of the feasibility stage of the development process, the Company has signed a Master Service Agreement which covers the optimisation, scale-up, technical transfer and manufacturing of the completed product, alongside comprehensive regulatory support.
Bango 95.00p £67.23m (BGO.L)
The mobile internet payment platform announces a strategic partnership with KT, a leading telecommunications provider in the Republic of Korea, to deliver subscription services to its 13.5m customers. Leveraging the Digital Vending Machine (DVM) from Bango, KT customers will benefit from new and exciting subscription services. This is the first major DVM agreement for Bango in Korea, building momentum for further expansion into the East Asia telco market. KT will use the Bango DVM to seamlessly integrate a wide array of third-party services into its subscriptions hub and its customer bundled offers. This will include AI, language and translation subscriptions, responding to the rising consumer appetite for next-generation digital experiences.
Christie Group 147.50p £39.79m (CTG.L)
The provider of Professional & Financial Services and Stock & Inventory Systems & Services to the hospitality, leisure, healthcare, medical, childcare & education and retail sectors updates on trading update for the financial year to date at today’s AGM. The Group has continued to benefit from encouraging levels of demand for its services, as lender and investor appetite into its chosen sectors has remained robust despite ongoing geopolitical uncertainty and the increased tax burden on employers in those same sectors. The Group's full year trading expectations are unchanged.
EARNZ 4.30p £3.27m (EARN.L)
The energy services Company whose objective is to capitalise on the drive for global decarbonisation announces a proposed placing at a price of 7.2p to raise gross proceeds of up to £1.02m. The Placing Price represents a premium of approximately 125 per cent. to the closing mid-market price of 3.2 pence on 11 June. EARNZ proposes to use the net proceeds of the Placing to provide working capital and to satisfy the £0.84m initial cash consideration payable for A&D Carbon Solutions LTD, a Company based in Wales which operates across the country, using a network of longstanding contractors delivering whole building solutions for the decarbonisation agenda, including external wall insulation, cavity wall insulation, air source heat pumps, and solar panels.
Feedback 14.75p £6.46m (FDBK.L)
The clinical infrastructure specialist announced that it has demonstrated the benefits of its Bleepa platform as part of the first ever simulation of the Neighbourhood Health Service in conjunction with the UK's leading enterprise management consultancy, PPL. Designed to generate insights at four levels: neighbourhood, place, system, and national, the immersive two-day simulation brought together over 100 representatives from across London's health and care systems to test a model that aims to build healthier communities and improved outcomes for Londoners. The transition to integrated neighbourhood teams will require a new digital infrastructure that allows multiple services to come together around the patient, both to share information and collaborate.
Fulcrum Metals 5.25p £3.26m (FMET.L)
The technology led Company focused on the recovery of precious metals from mine tailings in Canada announced the signing of a collaborative working agreement with Apitipi Anicinapek Nation (AAN) with respect to the Company's Teck Hughes and Sylvanite tailings projects in Kirkland Lake, Ontario. This Agreement formalises the collaboration between Fulcrum and AAN during the onsite evaluation phase of Fulcrum's gold tailings projects and also sets the foundation for future agreements on the shared benefits and opportunities as the Project's progress. Fulcrum and AAN have engaged in extensive consultations over time, exploring how they can work together on the responsible development of the Projects and other legacy mine waste sites in Ontario.
Gear4music (Holdings) 161.50p £31.47m (G4M.L)
The UK’s largest retailer of musical instruments and music equipment today announces that it has purchased stock with an estimated cost value of up to £2.4m, together with certain intangible assets including websites, trademarks, and commercial data, for a total consideration of up to £1.2m. These assets are being purchased from the Administrators of Jamm Co 2019 Ltd and its subsidiaries, including S&T Audio Limited trading as 'PMT Play Music Today'. For clarity, Gear4music is not acquiring any part of PMT's trading business, nor any other assets or liabilities, and has no current plans to use the PMT trading name. The Group will announce its Final Results for the year ended 31 March 2025, including an update on current trading, on 24 June.
Mind Gym 17.00p £17.06m (MIND.L)
The provider of human capital and business improvement solutions announces its results for YE March 2025. Revenue declined 14% to £38.6m, while gross profit margins increased by 42 bps to 86.6%n consequently the EBITDA improved to £1.9m from a loss of £0.3m in FY24. The LBT is £6.2m, down from a £12.1m loss which included exceptional and restructuring costs. A further cost reduction exercise will reduce operating and capital expenditure. The cash of £0.6m declined by £0.8m from FY24 and there is a new £4m overdraft facility.
Phoenix Copper Limited 5.40p £11.2m (PXC.L)
The USA focused base and precious metals emerging producer and exploration Company confirmed that further to its announcement on 14 November 2024, it has signed a Letter of Intent (LOI) with an accredited US based investor to subscribe for $75m of the Company's listed, secured floating rate minimum 8.5% corporate copper bonds due 2029-2033. Pursuant to the LOI, which is non-binding and subject to any further due diligence that may be required, placement of the Bonds is subject to the preparation and execution of definitive legal documentation, including the Bonds subscription letter. The LOI also provides for the issue to the Investor of a preference share of no par value convertible at £0.05 per share into 25m new ordinary shares of no par value, currently representing approximately 10.5% of the enlarged outstanding share capital of the Company, at any time between 1 September 2025 and 30 June 2028.
URU Metals Limited 4.3p £1.8m (URU.L)
The investment and project development Company announced an institutional investor proactively approached the Company to provide £420,000 at 3.5p. This strategic funding will accelerate the next phase of exploration at the Zeb Nickel Project in Limpopo, South Africa, positioning URU to unlock the potential of their nickel sulphide asset.
Status of this Note and Disclaimer
This document has been provided as a general market commentary and is issued to you by Hybridan LLP for information purposes only and should not be construed in any circumstances as investment advice; a recommendation; an offer to sell; nor solicitation of any offer to buy any security or other financial instrument. Nor shall it, or the fact of its distribution, form the basis of, or be relied upon in connection with, any contract relating to such action. The information has been provided without taking into account the investment objective, financial situation or needs of any particular person. Recipients should make their own investment decisions based upon their own financial objectives and financial resources and, if any doubt, should seek advice from an investment advisor.
As market commentary, this document is not investment research or a research recommendation for regulatory purposes as it does not constitute substantive research or analysis. It is not subject to any prohibition on dealing ahead of the dissemination of investment research although Hybridan LLP maintains related internal systems and controls in connection with such dealing.
This document should not be relied upon as being an independent or impartial view of the subject matter. The individuals who prepared this document may be involved in providing other financial services to the company or companies referenced in this document or to other companies who might be said to be competitors of the company or companies referenced in this document. As a result, both Hybridan LLP and the individual members, officers and/or employees who prepared this document may have responsibilities that conflict with the interests of the persons who receive this document. Hybridan LLP and/or connected persons may, from time to time, have positions in, make a market in and/or effect transactions in any investment or related investment mentioned herein and may provide financial services to the issuers of such investments.
This document is not intended to be an invitation or inducement to engage in investment activity. In the United Kingdom, this document is directed at and is for distribution only to persons who (i) fall within article 19(5) (persons who have professional experience in matters relating to investments) or article 49(2) (a) to (d) (high net worth companies, unincorporated associations, etc.) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (SI 2005/1529) (as amended) or (ii) persons who are categorised by Hybridan LLP as either a professional client or eligible counterparty (as those terms are defined in the Financial Conduct Authority's Conduct of Business Sourcebook) (all such persons referred to in (i) and (ii) together being referred to as "relevant persons"). This document must not be acted on or relied up on by persons who are not relevant persons. For the avoidance of doubt, this document is not intended for and should not be relied upon by any person who would be classified as a retail client under the Financial Conduct Authority's Conduct of Business Sourcebook.
The information contained in this document is based on materials and sources that are believed to be reliable; however, they have not been independently verified and are not guaranteed as being accurate. This document is not intended to be a complete statement or summary of any securities, markets, reports or developments referred to herein. The information may contain projections or other forward-looking statements regarding future events, targets or expectations. There is no assurance that such events or expectations will be achieved, and actual results may be significantly different from that shown here. The information is based on current market conditions, which will fluctuate and may be superseded by subsequent market events or for other reasons. Any and all opinions expressed are current opinions as of the date appearing on this document only. Any and all opinions expressed are subject to change without notice and Hybridan LLP is under no obligation to update the information contained herein.
References to specific securities, asset classes and financial markets are for illustrative purposes only. Past performance is no guarantee of future results. Information and opinions presented have been obtained or derived from sources which Hybridan LLP reasonably believed to be reliable however no representation or warranty, either express or implied, is made or accepted by Hybridan LLP, its members, directors, officers, employees, agents or associated undertakings in relation to the accuracy, completeness or reliability of the information in this document nor should it be relied upon as such.
To the fullest extent permitted by law, none of Hybridan LLP, its members, directors, officers, employees, agents or associated undertakings shall have any liability whatsoever for any losses arising in any way from use of all or any part of the information in this document including, for the avoidance of doubt, direct or indirect or consequential loss or damage (including lost profits).
Neither this document nor any copy of part thereof may be distributed in any other jurisdictions where its distribution may be restricted by law and persons into whose possession this document comes should inform themselves about, and observe, any such restrictions. Distribution of this report in any such other jurisdictions may constitute a violation of territorial and/or extra-territorial securities laws, whether in the United Kingdom or any other jurisdiction in any part of the world.
Hybridan LLP and/or its associated undertakings may from time-to-time provide investment advice or other services to, or solicit such business from, any of the companies referred to in this document. Accordingly, information may be available to Hybridan LLP that is not reflected in this material and Hybridan LLP may have acted upon or used the information prior to or immediately following its publication.
In addition, Hybridan LLP, the members, officers and/or employees thereof and/or any connected persons may have an interest in the securities, warrants, futures, options, derivatives or other financial instrument of any of the companies referred to in this document and may from time-to-time add or dispose of such interests.
Unless otherwise stated, Hybridan LLP owns the intellectual property rights and any other rights in this document. This document may not be copied, redistributed, resent, forwarded, disclosed or duplicated in any form or by any means, whether in whole or in part other than with the prior written consent of Hybridan LLP.
Hybridan LLP is a limited liability partnership registered in England and Wales, registered number OC325178, and is authorised and regulated by the Financial Conduct Authority and is a member of the London Stock Exchange. Any reference to a partner in relation to Hybridan LLP is to a member of Hybridan LLP or an employee with equivalent standing and qualifications. A list of the members of Hybridan LLP is available for inspection at the registered office, 2 Jardine House, The Harrovian Business Village, Bessborough Road, Harrow, Middlesex HA1 3EX.
This document, which does not constitute research, has been issued by Hybridan LLP for information purposes only and should not be construed in any circumstances as an offer to sell or solicitation of any offer to buy any security or other financial instrument, nor shall it, or the fact of its distribution, form the basis of, or be relied upon in connection with, any contract relating to any such action. This document has no regard for the specific investment objectives, financial situation or needs of any specific person or entity and is not a personal recommendation to any such person or entity. Recipients should reach an individual investment decision, based upon their respective financial objectives and financial resources and, if any doubt, should seek advice from an investment advisor.
The information contained in this document is based on materials and sources that are believed to be reliable; however, such information has not been independently verified and therefore it is not possible to confirm such information as being accurate. This document is not intended to be a complete statement or summary of any securities, markets, reports or developments referred to herein. No representation or warranty, either express or implied, is made or accepted by Hybridan LLP, its members, officers, employees, agents or associated undertakings in relation to the accuracy, completeness or reliability of the information contained in this document, nor should it be relied upon as such.
The content of this document includes market commentary and other information which we have prepared in relation to the company referred to in this document, which is our broking client. The provision of this document to you constitutes a minor non-monetary benefit which is capable of enhancing the quality of service provided by Hybridan LLP and which is of a scale and nature which could not be judged to impair the duty of Hybridan LLP to act in the best interest of its client falling within article 24(7)(b) of Regulation 600/2014/EU (MIFID II Regulation).
Any and all opinions expressed are current as of the date appearing on this face of this document only. Any and all opinions expressed are subject to change without notice and Hybridan LLP is under no obligation to update the information contained herein. To the fullest extent permitted by law, none of Hybridan LLP, its members, officers, employees, agents or associated undertakings shall have any liability whatsoever for any direct or indirect or consequential loss or damage (including lost profits) arising in any way from use of all or any part of the information in this document.
This document should not be relied upon as being an independent or impartial view of the subject matter and, for the avoidance of doubt, constitutes non-independent research (as such term is defined in the Financial Conduct Authority’s Conduct of Business Sourcebook to reflect the requirements of the MIFID II Regulation and Directive 2014/65/EU (known as MIFID II)). The individuals who prepared this document may be interested in shares in the company concerned and/or other companies within its sector, may be involved in providing other financial services to the company or companies referenced in this document or to other companies who might be said to be competitors of the company or companies referenced in this document. As a result both Hybridan LLP and the individual members, officers and/or employees who prepared this document may have responsibilities that conflict with the interests of the persons who receive this document. Hybridan LLP and/or connected persons may, from time to time, have positions in, make a market in and/or effect transactions in any investment or related investment mentioned herein and may provide financial services to the issuers of such investments.
In the United Kingdom, this document is directed at and is for distribution only to persons who (i) fall within article 19(5) (persons who have professional experience in matters relating to investments) or article 49(2) (a) to (d) (high net worth companies, unincorporated associations, etc.) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (SI 2005/1529) (as amended) or (ii) persons who are each a professional client or eligible counterparty (as those terms are defined in the Financial Conduct Authority’s Conduct of Business Sourcebook) of Hybridan LLP (all such persons referred to in (i) and (ii) together being referred to as relevant persons). This document must not be acted on or relied up on by persons who are not relevant persons. For the purposes of clarity, this document is not intended for and should not be relied upon by any person who would be classified as a retail client under the Financial Conduct Authority’s Conduct of Business Sourcebook.
Neither this document, nor any copy of part thereof may be distributed in any other jurisdictions where its distribution may be restricted by law and persons into whose possession this document comes should inform themselves about, and observe, any such restrictions. Distribution of this report in any such other jurisdictions may constitute a violation of territorial and/or extra-territorial securities laws, whether in the United Kingdom, the United States or any other jurisdiction in any part of the world.
Where possible this document is made available to all relevant recipients at the same time. Dissemination of research by Hybridan LLP is monitored to ensure that it is only provided to relevant persons. Research prepared by Hybridan LLP is not intended to be received and/or used by any person who is a retail client.
Hybridan LLP and/or its associated undertakings may from time-to-time provide investment advice or other services to, or solicit such business from, any of the companies referred to in this document. Accordingly, information may be available to Hybridan LLP that is not reflected in this material and Hybridan LLP may have acted upon or used the information prior to or immediately following its publication. In addition, Hybridan LLP, the members, officers and/or employees thereof and/or any connected persons may have an interest in the securities, warrants, futures, options, derivatives or other financial instrument of any of the companies referred to in this document and may from time-to-time add or dispose of such interests.
This document may not be copied, redistributed, resent, forwarded, disclosed or duplicated in any form or by any means, whether in whole or in part other than with the prior written consent of Hybridan LLP.
MIFID II status of Hybridan LLP research
The cost of production of our corporate research is met by retainers from our corporate broking clients. In addition, from time to time we issue further communications as market commentary (such as our daily newsletter, Small Cap Breakfast), which we consider to constitute a minor non-monetary benefit which is capable of enhancing the quality of service provided by Hybridan LLP and which is of a scale and nature which could not be judged to impair the duty of Hybridan LLP to act in the best interest of its client falling within article 24(7)(b) of the MIFID II Regulation.
Hybridan LLP is a limited liability partnership registered in England and Wales, registered number OC325178, and is authorised and regulated by the Financial Conduct Authority and is a member of the London Stock Exchange. Any reference to a partner in relation to Hybridan LLP is to a member of Hybridan LLP or an employee with equivalent standing and qualifications. A list of the members of Hybridan LLP is available for inspection at the registered office, 2 Jardine House, The Harrovian Business Village, Bessborough Road, Harrow, Middlesex HA1 3EX.
If you would like to unsubscribe, please email enquiries@hybridan.com with “unsubscribe me”.
